Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber)

Allergology International

Volumn 56, Issue 2, 2007, Pages 125-130

  Hashiguchi, Kazuhiro ^a   Tang, Huaipeng ^b   Fujita, Toshio ^b   Tsubaki, Shigeru ^c   Fujita, Masami ^d   Suematsu, Kiyochika ^e   Gotoh, Minoru ^f   Okubo, Kimihiro ^g  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

^b Shinryo Corporation   (Japan)

^c Samoncho Clinic

^d Medical Corporation Shinanokai

^e Chamber Business Department   (Japan)

^f NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Allergen exposure; Allergy symptoms; Artificial exposure chamber; Intranasal and intraocular pollen count; Japanese cedar pollen

Indexed keywords

ALLERGEN;

ADULT; AIR QUALITY CONTROL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HAY FEVER; HUMAN; JAPANESE; MALE; NOSE CAVITY; NOSE SECRETION; POLLEN ALLERGY; PRIORITY JOURNAL;

EID: 34250858914     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-453     Document Type: Article

References (13)

1. Okuda M. Epidemiology of Japanese cedar pollinosis throughout Japan. Ann. Allergy Asthma Immunol. 2003; 91:288-296.
2. Ishikawa T, Soh N. [Evaluation of quality of life (QOL) and efficacy of drug therapy on nasal symptoms and QOL disturbances in the patients with Japanese cedar pollinosis during the season of 2003 in Kyushu and Okinawa districts.]. Arerugi [Jpn. J. Allergol.] 2004;53:1131-1143 (in Japanese).
3. Kakutani C, Ogino S, Ikeda H, Enomoto T. [Impact of allergic rhinitis on work productivity: a pilot study.]. Arerugi [Jpn. J. Allergol.] 2005;54:627-635 (in Japanese).
4. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J. Allergy Clin. Immunol. 1996;97: 617-626.
5. Hyo S, Fujieda S, Kawada R, Kitazawa S, Takenaka H. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Ann. Allergy Asthma Immunol. 2005;94:457-464.
6. Horak F, Stubner P, Zieglmayer R et al. Controlled comparison of the efficacy and safety of Cetirizine 10 mg o.d. and Fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int. Arch. Allergy Immunol. 2001;125:73-79.
7. Day JH, Briscoe MP, Welsh A et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit Ann. Allergy Asthma Immunol. 1997;79:533-540.
8. Krug N, Hohlfeld JM, Geldmacher H et al. Effect of loteprednol etabonate nasal spray suspension on seasonal allegic rhinitis assessed by allergen challenge in an environmental exposure unit. Allergy 2005;60:354-359.
9. Enomoto T, Ide T, Ogino S. Development of an environmental exposure unit and effects of cetirizine hydrochloride on relieving the symptoms of cedar pollinosis. Prog. Med. 2005;25:3141-3149.
10. Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after conrtrolled ragweed pollen challenge in an environmental exposure unit.J. Allergy Clin. Immunol. 1998;101: 638-645.
11. Horak F, Stubner P, Zieglmayer R, big D, Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J. Allergy Clin. Immunol. 2002;109:956- 961.
12. Gotoh M, Okubo K, Okuda M. Inhibitory effects of face-masks and eyeglasses on invasion of pollen particles in the nose and eye: a clinical study. Rhinology 2005;43:266-270.
13. Okuda M, Ohkubo K, Gotoh M et al. Dynamics of air-borne pollen particles from inhalation to allergic reaction in the nose. Rhinology 2005;43:29-33.